Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

AISN · Integrating AI in Stroke Neurorehabilitation

HORIZONStatus: SIGNED1 December 202230 November 2026EU funding €5,940,894Call HORIZON-HLTH-2021-DISEASE-04

Health services are increasingly moving towards a treatment continuum aligned with the patient journey. This transition will critically depend on the successful deployment of trustworthy AI-enhanced technologies that are accurate, secure, and trusted. The AISN project will develop and validate operating procedures and guidelines for integrating AI in a healthcare continuum, focussing on post-stroke rehabilitation. AISN delivers a representative AI health platform built from integrating validated platforms for data acquisition and access, clinical interpretation, whole-brain simulation, clinically validated intervention delivery and optimization and model-based prediction. The AISN integrated platform will be validated in the clinical context of rehabilitation in the outpatient and at-home phase and facilitate a concrete assessment of the fundamental ways in which AI-enhanced clinical decision-support will change the care pathway and the formulation of novel AI compatible treatment guidelines. AISN ensures an ethical approach by developing legal and ethical guidelines for the robust, fair, and trustworthy deployment of AI in health and validating acceptance and transparency of its solutions. Building on the AISN platform, the project will test current standard operating procedures for integrating AI in health care and formulate and validate new ones where needed. The AISN guidelines and procedures will emphasize the evidence base and safety of clinical interventions, transparency, prognostics at varying time-scales, personalization of interventions, access to disease-specific information by clinicians, patients and their carers, and assure that the potential of AI is fully developed in the service of value-based medicine satisfying standards of security and safety. We will go beyond currently available guidelines and frameworks by emphasizing explainability, AI tools with evolving performance, and the dynamic interaction between users and algorithms.

Consortium · 18 organisations

coordinator

UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

ES · €180,644

participant

EBRAINS

BE · €150,168

participant

Centre hospitalier universitaire de Limoges

FR · €104,648

participant

FUNDACIO PRIVADA PER A LA RECERCA I LA DOCENCIA SANT JOAN DE DEU

ES · €354,125

participant

UNIVERSITE DE LIMOGES

FR · €200,665

participant

STICHTING RADBOUD UNIVERSITEIT

NL · €906,213

participant

UNIVERSITAT WIEN

AT · €279,371

participant

UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJ-NAPOCA

RO · €550,000

participant

TP21 GMBH

DE · €310,000

associatedPartner

INSEL GRUPPE AG

CH

participant

SADDLE POINT SCIENCE EUROPE BV

NL · €422,500

participant

EODYNE SYSTEMS SL

ES · €951,125

participant

SAN CAMILLO IRCCS SRL

IT · €350,000

participant

MEDTRONIC IBERICA SA

ES · €481,250

associatedPartner

LES HOPITAUX UNIVERSITAIRES DE GENEVE

CH

participant

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

DE · €700,185

associatedPartner

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

UK

thirdParty

PARC SANITARI SANT JOAN DE DEU

ES

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.